Vietnam National Network Of People Living With Hiv/Aids (Vnp+) Opposition, Lenacapavir, (Vn1201901371)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Baricitinib, (14607 / WO2009114512A1)
Countries: Viet Nam Date: 2022
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Bedaquiline, (12414 (Q1) /WO2008068231A1)
Countries: Viet Nam Date: 2022
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Bedaquiline, ( Patent No: 12414 (Q1) /WO2005117875A1)
Countries: Viet Nam Date: 2022
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, lopinavir/ritonavir (LPV/r) , (1/2007/01909 )
Countries: Viet Nam Date: 2012
-
Vietnam Network of People Living with HIV (VNP+) opposition, CAB-LA (Cabotegravir Long Active), (PCT/IB2020/061582 (Application No. VN 1-2022-03011))
Countries: Viet Nam Date: 2024
-
Vietnam Network of People Living with HIV (VNP+) opposition, Dolutegravir, (PCT/IB2021/055533 (VN1-0057835))
Countries: Viet Nam Date: 2026
-
Vietnam Network of People Living with HIV (VNP+) opposition, VH-499/ VH-280 (Dezecapavir), (PCT/IB2022/059780)
Countries: Viet Nam Date: 2026
-
Vietnam Network of People Living with HIV (VNP+) opposition, Rilpivirine, (PCT/US2021/072453)
Countries: Viet Nam Date: 2025
-
Vietnam Network of People Living with HIV (VNP+) opposition, Dolutegravir, (PCT/IB2021/055535)
Countries: Viet Nam Date: 2026
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (VN1-2021-07603 / WO/2021/250648)
Countries: Viet Nam Date: 2023